Dr Olivia Fletcher
Dr Olivia Fletcher obtained her first degree in Biochemistry at the University of Oxford, her PhD in the laboratory of Gene Structure and Expression at The National Institute of Medical Research, Mill Hill, and an MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine.
Dr Fletcher leads a team of genetic epidemiologists and molecular biologists, and is interested in using genetics - specifically information from genome-wide association studies - to understand the biology of breast cancer risk.
Dr Fletcher also uses intermediate end points - for example measurements of hormone levels - in her work; she has identified genetic variants that alter the way in which young women break down estrogens and shown that women with these genetic changes have lower levels of breast cancer risk.
Dr Minouk Schoemaker
I feel privileged to work on this study because thanks to over 100,000 women taking part we hope it will eventually aid prevention of breast cancer.
Dr Minouk Schoemaker studied environmental health sciences in the Netherlands and after moving to the UK completed MSc courses in radiation biology and medical statistics and subsequently received a PhD in Epidemiology from the University of London. She worked at the London School of Hygiene and Tropical Medicine before joining The Institute of Cancer Research. Her past work includes the study of risk factors for brain tumours and of cancer risks in patients with genetic abnormalities. She now continues to work on the management and scientific data analysis of the Breakthrough Generations Study.
Dr Michael Jones
It is exciting and rewarding to be working on the study because, through detailed and careful data collection and analysis, we aim to find ways to prevent breast cancer in future generations.
Dr Michael Jones studied Natural Sciences at Cambridge University, Applied Statistics at Oxford University, and received a PhD in Epidemiology from London University. He first worked in the field of cancer epidemiology in Australia, then in France at the International Agency for Research on Cancer, and later at the London School of Hygiene & Tropical Medicine. In 2001 he joined The Institute of Cancer Research and continues to work on the design, management and statistical analysis of complex, large epidemiological studies.